Oncotarget: Prognostic biomarker for patients with hepatocellular carcinoma

January 25, 2021

The cover for issue 52 of Oncotarget features Figure 1, "Volcano plots of DNA methylation in tumor tissues compared with nontumor tissue," published in "Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma" by Morine, et al. which reported that the authors conducted a genome-wide analysis of DNA methylation of the tumor and non-tumor tissue of 15 patients with Hepatocellular carcinoma (HCC), and revealed TBX15 was the most hypermethylated gene of the tumor.

Another validation set, which comprised 58 HCC with radical resection, was analyzed to investigate the relationships between tumor phenotype and TBX15 mRNA expression.

TBX15 mRNA levels in tumor tissues were significantly lower compared with those of nontumor tissues.

Multivariate analysis identified low TBX15 expression as an independent prognostic factor for overall and disease-free survival.

Therefore, genome-wide DNA methylation profiling indicates that hypermethylation and reduced expression of TBX15 in tumor tissue represents a potential biomarker for predicting poor survival of patients with HCC.

Reduced expression of TBX15 in tumor tissue represents a potential biomarker for predicting poor survival of patients with HCC

Dr. Yuji Morine from the Tokushima University Graduate School said, "Hepatocellular carcinoma (HCC) is the sixth most prevalent human cancer and third-highest cause of cancer-related deaths worldwide, and its incidence is significantly increasing."

Several genome-wide studies of the molecular alterations in tumor and non-tumor liver tissues addressed DNA, mRNA, and microRNA expression as well as epigenetic alterations to predict recurrence and hepatocarcinogenesis after treating patients with curative intent according to distinct gene expression or alteration patterns.

Here the Oncotarget authors focused on the epigenetic alterations of the genomes of the tumor and non-tumor cells of patients with HCC to identify the mechanisms of tumor progression and hepatocarcinogenesis because of global DNA hypomethylation or cancer specific DNA hypermethylation occurs in certain carcinomas.

They firstly chose long interspersed nuclear element-1 sequences that provided a surrogate marker of global DNA methylation levels and detected hypomethylation of LINE-1 in HCC tissues, which was significantly associated with poor prognosis of patients with HCC through the activation of MET.

Further, they investigated epigenetic characteristics with array-based analysis of DNA methylation using the Illumina Human Methylation 450 BeadChip and identified specific DNA methylation profiling in nontumor liver tissue of patients without HCV and HBV detectable infection, which possibly contributed to the development of HCC.

In this study, they analyzed DNA methylation profiles in tumor tissue of HCC using those case series of their recent study, and found the most hypermethylated gene in tumor compared with nontumor tissues, encodes T-box 15, implicating TBX15 as a candidate regulator of tumor progression.

The Morine Research Team concluded in their Oncotarget Research Paper that together, the present and previous findings support the importance of conducting further investigations to determine the role of TBX15 in cancer, particularly in tumor progression.

Second, selection bias was possible, because of the retrospective one.

Third, the authors did not determine the actual mechanism of TBX15 for tumor malignancy in a basic experiment.

Those issues should be solved in several cancers, to clarify the true function of TBX15 for tumor malignancy in each cancer.

In conclusion, reduced expression of TBX15 may serve as a potential biomarker for predicting tumor progression and poor survival as well as a target for antitumor therapy in HCC.

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27852

Full text - https://www.oncotarget.com/article/27852/text/

Correspondence to - Yuji Morine - ymorine@tokushima-u.ac.jp

Keywords - genome-wide analysis, methylation, tumor suppressor gene, prognostic biomarker, hepatocellular carcinoma

About Oncotarget

Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud -https://soundcloud.com/oncotarget
Facebook -https://www.facebook.com/Oncotarget/
Twitter -https://twitter.com/oncotarget
LinkedIn -https://www.linkedin.com/company/oncotarget
Pinterest -https://www.pinterest.com/oncotarget/
Reddit -https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls

Impact Journals LLC

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.